RADCOM director Bennun discloses initial share holdings
RADCOM LTD director Rachel (Heli) Bennun filed an initial Form 3 reporting her equity holdings in the company.
Rhea-AI Filing Summary
RADCOM LTD director Rachel (Heli) Bennun filed an initial Form 3 reporting her equity holdings in the company. She directly holds 82,340 Ordinary Shares, reflecting her existing ownership stake.
She also holds share options over 14,960 Ordinary Shares and a separate grant over 10,668 Ordinary Shares, each with an exercise price of $10.01 per share and an expiration date of October 15, 2034. Footnotes note one option grant was fully vested as of June 30, 2025, while another vests monthly from July 15, 2025 until October 15, 2026, and that her position includes 2,000 Ordinary Shares issuable upon vesting of restricted share units on a monthly schedule until July 21, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Share Options (right to buy) | -- | -- | -- |
| holding | Share Options (right to buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Footnotes (3)
- F1. Includes a total amount of 2,000 Ordinary Shares issuable upon the vesting of restricted share units on a monthly basis until July 21, 2026.
- F2. The options were granted on October 15, 2024, and are fully vested as of June 30, 2025.
- F3. The options were granted on October 15, 2024, and vest on a monthly basis, beginning July 15, 2025, until October 15, 2026.
Key Figures
Key Terms
Form 3 regulatory
vested financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the RADCOM (RDCM) Form 3 filed by Rachel (Heli) Bennun show?
What stock options are reported for Rachel (Heli) Bennun in RADCOM (RDCM)?
Does the RADCOM (RDCM) Form 3 indicate recent buying or selling by Bennun?
AI-generated analysis. How Rhea-AI works. Not financial advice.